Antigen: Breast Cancer 1, Early Onset Peptide 1
Available to For-Profits: Yes
Antigen Species: Human
Hybridoma Cells Available (Non-Profit): No
Isotype: MIgG1, kappa light chain
Depositor: Clinical Proteomics Technologies for Cancer
Host Species: mouse
Positive Tested Species Reactivity: Human
Depositors Institution: National Cancer Institute
Antigen Molecular Weight: 63.6 kDa
Depositors Notes: This monoclonal antibody recognizes non-phosphorylated CPTC-BRCA1 peptide 1. This antigen is also known as breast cancer type 1 susceptibility protein
Immunogen: Synthetic peptide
Alternate Antibody Name:
Alternate Gene Names: Breast Cancer 1, Early Onset; RNF53; RING Finger Protein 53; BROVCA1; PNCA4; PSCP; BRCA1/BRCA2-Containing Complex; Protein Phosphatase 1; Regulatory Subunit 53; Subunit 1; BRCAI; BRCC1; IRIS; PPP1R53; BRCA1/BRCA2-Containing Complex, Subunit 1; Breast And Ovarian Cancer Susceptibility Protein1; Breast Cancer Type 1 Susceptibility Protein; Protein Phosphatase 1, Regulatory Subunit 53; EC 6.3.2.
Alternate Antigen Name:
Myeloma Strain: P3x63Ag8.653
Epitope Mapped: Yes
Uniprot ID: P38398
Epitope Location or Sequence: a.a. 1520-1531
Entrez Gene ID: 672
Immunogen Sequence: RNYPSQEELIKV
Antibody Registry ID: AB_2722030
Additional Characterization: https://antibodies.cancer.gov/apps/site/detail/CPTC-BRCA1-2#CPTC-BRCA1-2
Recommended Applications: Immunoprecipitation
Additional Information: RRID:AB_2722030
These hybridomas were created by your colleagues. Please acknowledge the hybridoma contributor and the Developmental Studies Hybridoma Bank (DSHB) in the Materials and Methods of your publications. Please email the citation to us.
For your Materials & Methods section:
CPTC-BRCA1-2 was deposited to the DSHB by Clinical Proteomics Technologies for Cancer (DSHB Hybridoma Product CPTC-BRCA1-2)
Storage and Handling Recommendations
Although many cell products are maintained at 4°C for years without loss of activity, shelf-life at 4°C is highly variable. For immediate use, short term storage at 4°C up to two weeks is recommended. For long term storage, divide the solution into volumes of no less than 20 ul for freezing at -20°C or -80°C. The small volume aliquot should provide sufficient reagent for short term use. Freeze-thaw cycles should be avoided. For concentrate or bioreactor products, an equal volume of glycerol, a cryoprotectant, may be added prior to freezing.
The optimal Ig concentration for an application varies by species and antibody affinity. For each product, the antibody titer must be optimized for every application by the end user laboratory. A good starting concentration for immunohistochemistry (IHC), immunofluorescence (IF), and immunocytochemistry (ICC) when using mouse Ig is 2-5 ug/ml. For western blots, the recommended concentration range of mouse Ig 0.2-0.5 ug/ml. In general, rabbit antibodies demonstrate greater affinity and are used at a magnitude lower Ig concentration for initial testing. The recommended concentrations for rabbit Ig are 0.2-0.5 ug/ml (IF, IHC and ICC) and 20-50 ng/ml (WB).